Sponsor:
AbbVie
Code:
NCT06100744
Conditions
Juvenile Psoriatic Arthritis
Eligibility Criteria
Sex: All
Age: 5 - 18
Healthy Volunteers: Not accepted
Interventions
Adalimumab
Risankizumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations